Head Acupuncture Treat Residual Symptoms After Canalith Repositioning Procedure for BPPV

Launched by XI'AN NO.3 HOSPITAL · Aug 13, 2023

Keywords

ClinConnect Summary

This clinical trial is studying the use of electroacupuncture to help people with Benign Paroxysmal Positional Vertigo (BPPV) who still have symptoms after a successful repositioning treatment. While the repositioning maneuver usually helps relieve dizziness, some patients continue to experience issues like unsteady walking and feelings of discomfort. The trial aims to see if electroacupuncture can improve these remaining symptoms compared to another treatment, betahistine.

To join the trial, participants need to be between 65 and 74 years old and have been diagnosed with BPPV, having successfully undergone the repositioning maneuver. They should still have some lingering symptoms but no major communication or vision problems. This study is open to all genders, and participants should be willing to follow the treatment plan agreed upon with their family. Those with certain other health issues or who cannot handle the treatment will not be eligible. Participants can expect to receive either the acupuncture treatment or the medication while being monitored for improvements in their symptoms.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. According to the diagnostic criteria and therapeutic efficacy evaluation for benign paroxysmal positional vertigo (BPPV) formulated by the Otolaryngology-Head and Neck Surgery Branch of the Chinese Medical Association, the patient was confirmed as having BPPV and the repositioning maneuver was successful.
• • 2. After the maneuver, the patient's clinical symptoms were relieved, with no sense of rotation or dizziness, but residual symptoms such as discomfort and unsteady gait persisted.
• • 3. There were no obvious communication barriers or visual impairments.
• • 4. The patient and their family members agreed to the treatment plan.
• Exclusion Criteria:
• • Patients with other ear diseases, history of head trauma or surgery;
• • Patients who are weak and unable to tolerate, pregnant women;
• • Patients who have undergone vestibular rehabilitation training before this treatment; ④ Patients with joint diseases that affect balance and walking; ⑤ Patients with a history of brain organic diseases (such as tumors, stroke, cerebral hemorrhage) or severe neurological diseases; ⑥ Patients with incomplete data or who withdraw from treatment midway.